<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <chamber>Senate</chamber>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <systemCode>sshr00</systemCode>
          <subcommittees />
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-05-09T20:07:14Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <congress>115</congress>
    <originChamber>Senate</originChamber>
    <version>1.0.0</version>
    <summaries>
      <billSummaries>
        <item>
          <name>Introduced in Senate</name>
          <text><![CDATA[<p><b>FDA Accountability for Public Safety Act</b></p> <p>This bill amends the Comprehensive Addiction and Recovery Act of 2016 to expand the scope of the Food and Drug Administration (FDA) advisory committee to make recommendations regarding supplemental applications for opioids. Currently, the committee only makes recommendations on new drug applications. </p> <p>Only the Commissioner of Food and Drugs may approve a new drug application or supplement to an application for an opioid against the recommendation of the committee. If the Commissioner approves a drug against the recommendation of the committee, the Commissioner must: (1) submit a report to Congress that includes the evidence regarding patient safety that supports the Commissioner's decision and a disclosure of any potential conflicts of interest of FDA officials involved in the decision; and (2) testify before Congress regarding the decision, upon request. Such a drug cannot be sold until the Commissioner has submitted the report.</p>]]></text>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2018-05-08T20:53:42Z</lastSummaryUpdateDate>
          <actionDate>2017-05-09</actionDate>
          <updateDate>2017-05-09T04:00:00Z</updateDate>
          <versionCode>00</versionCode>
        </item>
      </billSummaries>
    </summaries>
    <billNumber>1078</billNumber>
    <relatedBills />
    <laws />
    <billType>S</billType>
    <calendarNumbers />
    <recordedVotes />
    <textVersions>
      <item>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115s1078is/xml/BILLS-115s1078is.xml</url>
          </item>
        </formats>
        <date>2017-05-09T04:00:00Z</date>
        <type>Introduced in Senate</type>
      </item>
    </textVersions>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <cosponsors>
      <item>
        <identifiers>
          <bioguideId>C001047</bioguideId>
          <lisID>1676</lisID>
          <gpoId>8223</gpoId>
        </identifiers>
        <bioguideId>C001047</bioguideId>
        <middleName>MOORE</middleName>
        <party>R</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Capito, Shelley Moore [R-WV]</fullName>
        <lastName>CAPITO</lastName>
        <state>WV</state>
        <firstName>SHELLEY</firstName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2017-05-09</sponsorshipDate>
      </item>
      <item>
        <identifiers>
          <bioguideId>M001170</bioguideId>
          <lisID>1820</lisID>
          <gpoId>8252</gpoId>
        </identifiers>
        <bioguideId>M001170</bioguideId>
        <middleName />
        <party>D</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. McCaskill, Claire [D-MO]</fullName>
        <lastName>McCaskill</lastName>
        <state>MO</state>
        <firstName>Claire</firstName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2017-05-09</sponsorshipDate>
      </item>
      <item>
        <identifiers>
          <bioguideId>K000383</bioguideId>
          <lisID>2185</lisID>
          <gpoId />
        </identifiers>
        <bioguideId>K000383</bioguideId>
        <middleName />
        <party>I</party>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. King, Angus S., Jr. [I-ME]</fullName>
        <lastName>King</lastName>
        <state>ME</state>
        <firstName>Angus</firstName>
        <sponsorshipWithdrawnDate />
        <sponsorshipDate>2017-05-09</sponsorshipDate>
      </item>
    </cosponsors>
    <createDate>2017-05-10T08:26:49Z</createDate>
    <title>FDA Accountability for Public Safety Act</title>
    <amendments />
    <actions>
      <item>
        <actionDate>2017-05-09</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <type>IntroReferral</type>
        <committee />
        <actionCode>10000</actionCode>
        <actionDate>2017-05-09</actionDate>
        <links />
        <text>Introduced in Senate</text>
      </item>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInSenate>1</introducedInSenate>
        <referredToCommittee>1</referredToCommittee>
      </actionTypeCounts>
    </actions>
    <introducedDate>2017-05-09</introducedDate>
    <committeeReports />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Federal officials</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Government ethics and transparency, public corruption</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <sponsors>
      <item>
        <state>WV</state>
        <fullName>Sen. Manchin, Joe, III [D-WV]</fullName>
        <party>D</party>
        <lastName>Manchin</lastName>
        <firstName>Joe</firstName>
        <identifiers>
          <bioguideId>M001183</bioguideId>
          <gpoId>8256</gpoId>
          <lisID>1983</lisID>
        </identifiers>
        <middleName />
        <byRequestType />
        <bioguideId>M001183</bioguideId>
      </item>
    </sponsors>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>A bill to establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.</title>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>FDA Accountability for Public Safety Act</title>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>FDA Accountability for Public Safety Act</title>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>FDA Accountability for Public Safety Act</title>
        <chamberName />
        <chamberCode />
      </item>
    </titles>
    <updateDate>2019-04-18T16:35:55Z</updateDate>
    <notes />
    <latestAction>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <actionDate>2017-05-09</actionDate>
      <links />
    </latestAction>
    <cboCostEstimates />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

